woundcarping said:I'd also weigh your goals vs trial data outcomes and see where you land. For example, if you're wanting to lose 30+% of your starting weight, Reta doubles or better* the likelihood vs Tirz comparing 48 week Reta trial data to 72 week Tirz data. *Reta hadn't reached plateau at 48 weeks while Tirz had at 72 weeks.
A new idea/concept I'm exploring that I got from @Grogu is the idea that our bodies adapt to the peptides in a given time, not a given dose.... the various doses curves are all similar and plateau at similar timings. Antithetical to the idea of "low and slow"... but to my knowledge there haven't been studies to show the effects of increasing dose after the plateau and observing weigh changes and comparing that to being at a higher dose before the plateau.
Yes, no studies looking at what happens if we keep increasing doses in the period we would anticipate plateaus on these medications and absolutely no studies about changing pathways in the same period (e.g. adding an amylin receptor agonist, adding phentermine/topiramate, or even metformin).
I remember an interview a while back with Dr. Jastreboff, the lead researcher on most of the tirzepatide clinical trials, and someone asked her what happens if someone doesn't achieve the desired weightloss on tirzepatide. And she said something to the effect that depending on someone's level of obesity, multiple medications might be necessary if goal isn't reached. If one stops working then she would switch the patient to another medication.

